CSLN Stock Chart & Stats
$2081.30
$0.00(0.00%)
At close: 4:00 PM EDT
$2081.30
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$2,077.68 - $3,312.29
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$747.56B
Enterprise Value$101.61K
Total Cash (Recent Filing)$1.15B
Total Debt (Recent Filing)$12.58B
Price to Earnings (P/E)29.0
Beta-0.13
Next Earnings
Aug 18, 2026EPS Estimate
40.86Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.98
Shares Outstanding478,912,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio2.89
Price to Book (P/B)5.99
Price to Sales (P/S)7.51
P/FCF Ratio45.55
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1,611.29Price Target Upside-22.58% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)77.67
Revenue Forecast (FY)$189.00B
CSL News
CSLN FAQ
What was CSL’s price range in the past 12 months?
CSL lowest stock price was $2077.68 and its highest was $3312.29 in the past 12 months.
What is CSL’s market cap?
CSL’s market cap is $747.56B.
When is CSL’s upcoming earnings report date?
CSL’s upcoming earnings report date is Aug 18, 2026 which is in 17 days.
How were CSL’s earnings last quarter?
CSL released its earnings results on Feb 10, 2026. The company reported $69.925 earnings per share for the quarter, missing the consensus estimate of $71.834 by -$1.909.
Is CSL overvalued?
According to Wall Street analysts CSL’s price is currently Overvalued.
Does CSL pay dividends?
CSL does not currently pay dividends.
What is CSL’s EPS estimate?
CSL’s EPS estimate is 40.86.
How many shares outstanding does CSL have?
CSL has 478,912,000 shares outstanding.
What happened to CSL’s price movement after its last earnings report?
CSL reported an EPS of $69.925 in its last earnings report, missing expectations of $71.834. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of CSL?
Currently, no hedge funds are holding shares in MX:CSLN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CSL Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1,611.29 (-22.58% Downside)
$1,611.29 (-22.58% Downside)
Blogger Sentiment
Bullish
MX:CSLN Sentiment 81%
Sector Average 65%
Sector Average 65%
Insider Transactions
Bought Shares
Worth $5.6M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 90%
Bearish news 10%
Bearish news 10%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-48.44%
12-Months-Change
Fundamentals
Return on Equity
2.95%
Trailing 12-Months
Asset Growth
-1.42%
Trailing 12-Months
Company Description
CSL
CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
CSLN Stock 12 Month Forecast
Average Price Target
$1,611.29
▼(-22.58% Downside)